Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 54

1.

[Cell survival: differences and differentiation].

Vachon PH.

Med Sci (Paris). 2006 Apr;22(4):423-9. Review. French.

2.

Integrin signaling, cell survival, and anoikis: distinctions, differences, and differentiation.

Vachon PH.

J Signal Transduct. 2011;2011:738137. doi: 10.1155/2011/738137. Epub 2011 Jul 13.

3.

Cellular growth and survival are mediated by beta 1 integrins in normal human breast epithelium but not in breast carcinoma.

Howlett AR, Bailey N, Damsky C, Petersen OW, Bissell MJ.

J Cell Sci. 1995 May;108 ( Pt 5):1945-57.

4.

Chondrocyte-matrix attachment complexes mediate survival and differentiation.

Svoboda KK.

Microsc Res Tech. 1998 Oct 15;43(2):111-22. Review.

PMID:
9822998
5.

Anoikis mechanisms.

Frisch SM, Screaton RA.

Curr Opin Cell Biol. 2001 Oct;13(5):555-62. Review.

PMID:
11544023
6.

Early loss of E-cadherin from cell-cell contacts is involved in the onset of Anoikis in enterocytes.

Fouquet S, Lugo-Martínez VH, Faussat AM, Renaud F, Cardot P, Chambaz J, Pinçon-Raymond M, Thenet S.

J Biol Chem. 2004 Oct 8;279(41):43061-9. Epub 2004 Aug 2.

7.

[Control of the survival/apoptosis balance by E-cadherin: role in enterocyte anoikis].

Fouquet S, Lugo-Martínez VH, Chambaz J, Cardot P, Pinçon-Raymond M, Thenet S.

J Soc Biol. 2004;198(4):379-83. Review. French.

PMID:
15969344
9.

Activation of metalloproteinases and their association with integrins: an auxiliary apoptotic pathway in human endothelial cells.

Levkau B, Kenagy RD, Karsan A, Weitkamp B, Clowes AW, Ross R, Raines EW.

Cell Death Differ. 2002 Dec;9(12):1360-7.

10.

Get a ligand, get a life: integrins, signaling and cell survival.

Stupack DG, Cheresh DA.

J Cell Sci. 2002 Oct 1;115(Pt 19):3729-38. Review.

11.

Biosynthesized matrix provides a key role for survival signaling in bronchial epithelial cells.

Wadsworth SJ, Freyer AM, Corteling RL, Hall IP.

Am J Physiol Lung Cell Mol Physiol. 2004 Mar;286(3):L596-603. Epub 2003 Nov 14.

12.
13.
14.
15.

Dependence receptors: a new paradigm in cell signaling and cancer therapy.

Goldschneider D, Mehlen P.

Oncogene. 2010 Apr 1;29(13):1865-82. doi: 10.1038/onc.2010.13. Epub 2010 Feb 22. Review.

PMID:
20173780
16.

Urokinase signaling through its receptor protects against anoikis by increasing BCL-xL expression levels.

Alfano D, Iaccarino I, Stoppelli MP.

J Biol Chem. 2006 Jun 30;281(26):17758-67. Epub 2006 Apr 21.

18.

Receptor-interacting protein shuttles between cell death and survival signaling pathways.

Kamarajan P, Bunek J, Lin Y, Nunez G, Kapila YL.

Mol Biol Cell. 2010 Feb 1;21(3):481-8. doi: 10.1091/mbc.E09-06-0530. Epub 2009 Dec 2.

19.

Anoikis.

Valentijn AJ, Zouq N, Gilmore AP.

Biochem Soc Trans. 2004 Jun;32(Pt3):421-5. Review.

PMID:
15157151
20.

Growth factor signaling in cell survival: implications for cancer treatment.

Talapatra S, Thompson CB.

J Pharmacol Exp Ther. 2001 Sep;298(3):873-8. Review.

Supplemental Content

Support Center